The Milano Project

Fund the research that could end PFS & PSSD

  • The University of Milan is mapping the biology behind PFS and PSSD.
  • Seven studies — the most comprehensive programme yet.
  • Donations pay for it. Yours funds the next study.
PFS Foundation University of Milan SIDEfxHUB
The Numbers

The Milano Project by the numbers

7 Studies planned The most comprehensive programme these conditions have had
1 Published so far Results from the second are due
100 Donors worldwide Funded by the people who live it
2026 All seven studies complete With the final paper published in 2027

From laboratory to treatment

Your donation funds the research turning PFS and PSSD from mystery into biology.

  • Real science, real progressLed by Prof. Roberto Melcangi, University of Milan
  • Shared pathways, shared solutionsStudying PFS and PSSD together
  • Hope backed by dataAlready shaping diagnosis and treatment
  • Patient-driven changeFunded by those who live it

Every donation moves this forward.

Published Research

Milano Project studies

1 out of 7 studies published

Results From Study 1

Allopregnanolone Alleviates Some Symptoms of Finasteride-induced Inflammation in Both the Gut and Hypothalamus of Rats

The study shows that finasteride withdrawal triggers inflammation in both gut and hypothalamus in rats, and that allopregnanolone (ALLO) can reverse several of these effects, including restoring the potential PFS biomarker PPAR-alpha. This confirms gut-brain disruption in PFS, identifies a viable treatment candidate, and moves the Milano Project closer to real therapeutic options.

Results from the second study will be shared soon.

Roadmap

What your donation actually pays for

2024–2026

Complete 7 human investigations on PFS and PSSD

The most comprehensive study programme ever conducted on these conditions.

Ongoing

Identify biomarkers proving the biological basis

Building objective, measurable evidence that clinicians and regulators can act on.

Ongoing

Map neurosteroid synthesis disruption

Understanding how finasteride and SSRIs affect allopregnanolone and related pathways.

2026+

Build foundation for clinical trials in Italy

Moving from lab research to human treatment trials.

Always

Share all data with qualified researchers worldwide

Open science for the benefit of every patient.

Documentary

Inside the Milano Project

Join Robb as he travels to Italy to meet Professor Melcangi and his team. Step inside the lab, meet the PhD students running advanced neurosteroid and molecular assays — and hear directly from the scientists behind this historic effort.

“This is not theory. It is science that is happening now.”

— Robb, SIDEfxHUB

Committed to the science, and to the people living with PFS & PSSD

The Milano Project represents a collaboration built on integrity, expertise, and genuine commitment — a team whose dedication to understanding PFS and PSSD is both scientific and deeply human.

For over a decade, they have worked quietly and rigorously to uncover the biological mechanisms behind these conditions, driven not by recognition but by responsibility. Their research stands as a beacon of hope for a community that has long been overlooked.

Prof. Melcangi's team at work in the Milano Project lab
“We are no longer in the dark. The evidence is strong — and the next step is human clinical trials.”
— Prof. Roberto Melcangi
Partners

Other ongoing research

Support ongoing research into PFS and PSSD through our partner organisations.

PSSD Network

PSSD Network

Contributes to the Milano Project led by Dr. Melcangi. Explores neurological and hormonal causes of PSSD, investigates brain function and gut health, studies steroid imbalances, identifies potential biomarkers.

Learn more and donate
RxISK

RxISK

Investigates PSSD through nerve imaging and biomarkers, tests light therapy, explores links between SSRIs and p63 protein changes. Offers the $100K RxISK Prize for treatment breakthroughs.

Learn more and donate

Thank you from team SIDEfxHUB

Every contribution funds work that would not otherwise be done. We are grateful to stand alongside a community that has had to fight to be believed, and that is now funding the evidence to end that.

Gary Shields

Gary Shields

Legal & Compliance Director

Robb Dixon

Robb Dixon

Communications Director

Morten Skov

Morten Skov

Digital & Awareness Director

Ryan Clark

Ryan Clark

Community Director

If you are in crisis: 116 123 Samaritans (UK) 988 Lifeline (US) Find a helpline